SUMO Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of SUMO monoclonal antibodies for various research applications. SUMO monoclonal antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Small Ubiquitin-like Modifier (SUMO) proteins play a central role in post-translational modifications, influencing cellular processes including protein stability, localization, and activity. The SUMOylation process regulates gene expression, DNA repair, and cell cycle progression, making it significant in both normal cellular function and disease states. Understanding the dynamics of SUMOylation provides insights into cancer biology, neurodegenerative diseases, and other pathologies. Researchers worldwide utilize SUMO monoclonal antibodies to investigate cellular mechanisms and pathways. Advanced research with SUMO monoclonal antibodies has revealed new understanding of protein regulation and cellular signaling networks. SUMO monoclonal antibodies enable detailed examination of protein modifications in health and disease. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific knowledge and developing potential therapeutic strategies.